Long-Term Safety and Efficacy of KL1333 in Adults with Primary Mitochondrial Disease
- Substances:Napazimone
The Netherlands- Participants:18–64 years · 65+ years
- Substances:Napazimone
- Sponsor:Pharming Technologies B.V.
Rare diseases
Investigational molecules
Locations
Back to the Netherlands842 clinical trials in Zutphen, The Netherlands across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in the NetherlandsKlinischOnderzoek.nl(opens in a new tab)
The NetherlandsStudy of ELA026 for Treatment of Secondary Hemophagocytic Lymphohistiocytosis in Patients with Lymphoma Who Have Not Received Previous Treatment
The NetherlandsStudy on Golcadomide for Patients with Relapsed or Refractory Large B-Cell Lymphoma in the Brain
The NetherlandsStudy on the Effects of Baricitinib and Drug Combination for Adults with Severe Community-Acquired Pneumonia, Severe Influenza, or Severe and Moderate COVID-19
The NetherlandsStudy on Long-Term Safety of Lutetium (177Lu) Vipivotide Tetraxetan for Adults with Prostate Cancer
The NetherlandsStudy Comparing Clindamycin to Rifampicin and Drug Combination for Patients with Prosthetic Joint Infection
The NetherlandsStudy on Early Diffuse Cutaneous Systemic Sclerosis: Comparing Stem Cell Transplantation with Cyclophosphamide, Filgrastim, and Mycophenolate Mofetil
The NetherlandsFirst-line treatment of metastatic non‑small cell lung cancer with high PD‑L1 expression: ivonescimab versus pembrolizumab
The NetherlandsA Phase II Randomized, Double‑Blind Study of RO7568282 for Safety and Efficacy in Early‑Stage Parkinson’s Disease Patients
The NetherlandsPhase 3 Study of Subcutaneous vs Intravenous Tarlatamab with Siltuximab in Relapsed Extensive-Stage Small Cell Lung Cancer after Platinum Chemotherapy
The NetherlandsPhase 3 Study of GSK6042981 versus Imatinib in Adults with Previously Untreated Metastatic or Unresectable Gastrointestinal Stromal Tumors (GIST)
The NetherlandsStudy of pirtobrutinib plus epcoritamab in patients with relapsed or refractory chronic lymphocytic leukemia or small lymphocytic lymphoma
The NetherlandsThe busiest research cities in the country
What the registry says about research in the country
Clinical research focusing on respiratory conditions including innovative treatments for asthma and viral infections. Studies encompass evaluation of new vaccine combinations and safety assessments of inhalation devices.
Investigations include both preventive measures and therapeutic interventions for respiratory conditions.
Comprehensive research into cardiovascular health, examining treatments for various heart conditions and prevention of major cardiac events.
Focus on innovative therapies and interventions to improve patient outcomes in heart-related conditions.
Advanced studies in lung cancer treatment and innovative therapeutic approaches for various cancer types.
Evaluating novel treatment combinations and immunotherapy approaches for better patient outcomes.
Tell us about your condition – we search every trial in Europe and connect you with the right site.